Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 1,267 results.

Thumbnail for Plasma Cytokeratin-18 Fragment in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia

AML - 107

Plasma Cytokeratin-18 Fragment in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia

Mostafa El Razzaz

Poster Presenter: Mostafa El Razzaz

Thumbnail for CRHBP Activates NF-κB Signaling Through TNIP1 Inhibition in Leukemic Stem Cells: A Novel CRH-Independent Mechanism of Treatment Resistance

AML - 109

CRHBP Activates NF-κB Signaling Through TNIP1 Inhibition in Leukemic Stem Cells: A Novel CRH-Independent Mechanism of Treatment Resistance

Ryutaro Taenaka

Poster Presenter: Ryutaro Taenaka

Thumbnail for Updated Overall Survival (OS) and Long-Term Transfusion Independence (TI) From the Phase 3 COMMANDS Trial in Erythropoiesis-Stimulating Agent (ESA)-Naive Patients With Lower-Risk Myelodysplastic Syndromes (LR-MDS)

Previous 1...7 8 9 10 11 12 13...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

MDS - 113

Updated Overall Survival (OS) and Long-Term Transfusion Independence (TI) From the Phase 3 COMMANDS Trial in Erythropoiesis-Stimulating Agent (ESA)-Naive Patients With Lower-Risk Myelodysplastic Syndromes (LR-MDS)

Guillermo Garcia-Manero

Poster Presenter: Guillermo Garcia-Manero

Thumbnail for Phenotype-Specific Safety Reporting Signals of Asciminib Versus Second- and Third-Generation Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A FAERS Disproportionality Analysis

CML - 115

Phenotype-Specific Safety Reporting Signals of Asciminib Versus Second- and Third-Generation Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A FAERS Disproportionality Analysis

Edward Mwarangu

Poster Presenter: Edward Mwarangu

Thumbnail for AI-Assisted Simplification of Clinic Notes for Patients With Plasma Cell Dyscrasias and Myeloid Neoplasms to Improve Patient Understanding and Satisfaction: A Prospective Pilot Study

MM - 116

AI-Assisted Simplification of Clinic Notes for Patients With Plasma Cell Dyscrasias and Myeloid Neoplasms to Improve Patient Understanding and Satisfaction: A Prospective Pilot Study

Karun Neupane

Poster Presenter: Karun Neupane

Thumbnail for TP53 Functional Classification Association With Response and Survival Outcomes in AML and High-Risk MDS

AML - 117

TP53 Functional Classification Association With Response and Survival Outcomes in AML and High-Risk MDS

Qi Tatarata

Poster Presenter: Qi Tatarata

Thumbnail for Clinical Outcomes and Predictors of Early Inpatient CAR-T Administration Within 48 Hours: A Nationwide Analysis

CLL - 119

Clinical Outcomes and Predictors of Early Inpatient CAR-T Administration Within 48 Hours: A Nationwide Analysis

Fiqe Khan

Poster Presenter: Fiqe Khan

Thumbnail for A Rare Case of ZBTB16-RARA Fusion Acute Myeloid Leukemia Mimicking APL: Diagnostic Challenges and Successful CLIA + Venetoclax Therapy

AML - 121

A Rare Case of ZBTB16-RARA Fusion Acute Myeloid Leukemia Mimicking APL: Diagnostic Challenges and Successful CLIA + Venetoclax Therapy

Gamaliel Monge-Ruiz

Poster Presenter: Gamaliel Monge-Ruiz

Thumbnail for Divergent Trends in Chronic Myeloid Leukemia Mortality Associated with Cardiovascular Comorbidities in the United States (2018-2024): A CDC WONDER and GBD Analysis Highlighting Persistent Survivorship Risk

CML - 124

Divergent Trends in Chronic Myeloid Leukemia Mortality Associated with Cardiovascular Comorbidities in the United States (2018-2024): A CDC WONDER and GBD Analysis Highlighting Persistent Survivorship Risk

Tapan Giri

Poster Presenter: Tapan Giri

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.